课题基金 / 基金详情

Synthesis and antioxidant activity of vitamin C analogs and vitamin E analogs

Synthesis and antioxidant activity of vitamin C analogs and vitamin E analogs
维生素C类似物和维生素E类似物的合成及其抗氧化活性
批准号:
11672217
负责人:
MASHINO Tadahiko
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MASHINO Tadahiko的其他基金

相似基金

相关文献

中文摘要
翻译
活性氧(ROS)和自由基诱导氧化应激,并在人类疾病如癌症的发生和/或进展中起重要作用。因此,抗氧化剂有望成为一种良好的药物先导化合物。在这项研究中,我们开发了基于维生素C和E.1的优秀抗氧化剂。设计并合成了苯并[h]色满类化合物(BC),用ESR自旋捕捉法研究了BC对超氧阴离子和OH自由基的猝灭活性。这两种活性均高于维生素E水溶性类似物trolox.维生素C类似物还原酸(RA)是一种在5元碳环上有一个羰基与2,3-烯醇共轭的化合物。RA抑制黄嘌呤氧化酶的活性,而抗坏血酸没有。RA淬灭自由基,并减少活性氧的产生。黄嘌呤氧化酶产生尿酸,尿酸在山羊体内起重要作用。因此,黄嘌呤氧化酶抑制剂可作为山羊的药物。RA被认为是一种很有前途的氧化应激抑制剂和山羊的治疗药物。我们的数据表明,BC和RA是一个新的起始结构,用于设计抗肿瘤的化合物,如癌症。
英文摘要
Reactive oxygen species (ROS) and free radicals induce oxidative stress and play the important role in developing and/or progression of human diseases such as cancer. So, antioxidants are expected to be a good lead compounds for medicines. In this study, we developed excellent antioxidants based vitamin C and E.1. Vitamin E analogsWe designed and synthesized benzo[h]chroman compounds (BC) which had benzene ring fused with vitamin E skelton and examined superoxide and OH radical quenching activity by ESR spin-trapping methods. Both activities were higher than that of trolox, which is vitamin E water-soluble analog.2. Vitamin C analogsReductic acid (RA) which has a 2,3-enediol moiety conjugated with a carbonyl group in a five-membered carbon ring was synthesized. RA inhibited xanthine oxidase activity, while ascorbic acid did not.RA quenched free radicals and also decreases active oxygen production. RA is thought to be a more potent inhibitor of active oxygen toxicity than ascorbic acid.Xanthine oxidase produces uric acid, which plays a crucial role in goat. Therefore, xanthine oxidase inhibitor works as a medicine for goat. RA is thought to be a promising inhibitor for oxidative stress and remedy for goat.Our data showed that BC and RA serves as a new starting structure for the design of pharmacologically effective compounds such as cancer.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Xanthine oxidase阻害活性を有する抗酸化剤の開発.
开发具有黄嘌呤氧化酶抑制活性的抗氧化剂。
DOI: --
发表时间: 2000
期刊:
影响因子: --
作者: [滝川靖, 増野匡彦, 他]
通讯作者: 他
DOI: --
发表时间: 2000
期刊: Bioorg. Med.Chem.Lett. 10
影响因子: --
作者: [T.Mashino, et at]
通讯作者: et at
DOI: --
发表时间: 2000
期刊:
影响因子: --
作者: [T.Mashino, et al.]
通讯作者: et al.
DOI: --
发表时间: 2000
期刊:
影响因子: --
作者: [T.Mashino, et al.]
通讯作者: et al.
共 8 条
    Development of novel antimicrobial agent with the fullerene skeleton
    • 批准号:
      13672327
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      2001
    • 负责人:
      MASHINO Tadahiko
    • 依托单位:
    国内基金
    海外基金
    Vitamin E抑制胞浆APE1/Beclin1信号途径克服肺癌EGFR T790M突变耐药及机制研究
    Vitamin E脂质体纳米颗粒携带siRNA靶向抑制HCV的实验研究
    • 批准号:
      81171628
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2011
    • 负责人:
      陈维贤
    • 依托单位: